|
業務類別
|
Biotechnology |
|
業務概覽
|
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases. |
| 公司地址
| 5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057 |
| 電話號碼
| +1 800 587-8170 |
| 傳真號碼
| -- |
| 公司網頁
| https://www.coyatherapeutics.com |
| 員工數量
| 8 |
| Dr. Arun Swaminathan, PhD |
Chief Executive Officer and Director |
美元 441.67K |
16/05/2025 |
| Dr. Fred Grossman |
President and Chief Medical Officer |
美元 479.00K |
16/05/2025 |
| Mr. David S. Snyder, M.B.A. |
Principal Accounting Officer, Chief Financial Officer and Chief Operating Officer |
美元 425.00K |
16/05/2025 |
|
|
| Mr. Wilbur L. Ross, Jr |
Independent Director |
16/05/2025 |
| Dr. Arun Swaminathan, PhD |
Chief Executive Officer and Director |
16/05/2025 |
| Mr. Dieter Weinand |
Independent Director |
16/05/2025 |
| Dr. Anabella Villalobos, PhD |
Independent Director |
16/05/2025 |
| Dr. Howard Berman, PhD |
Executive Chairman of the Board |
16/05/2025 |
| Dr. Ann Lee, PhD |
Independent Director |
16/05/2025 |
| Dr. Dov A. Goldstein, M.B.A.,M.D. |
Independent Director |
16/05/2025 |
|
|
|
|
